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The surgical management of craniopharyngiomas in children remains one of the more con-
troversial topics in pediatric neurosurgery.Theoretically, the benign histology implies that
total surgical excision would be sufﬁcient to provide a cure. It has been widely established
however, that in certain cases total excision may lead to unacceptable hypothalamic injury.
The therapeutic goals for pediatric craniopharyngiomas therefore, require not just cure of
the disease but also preservation of function. Over the last 15years, there has been a
growing worldwide advocacy for less extensive resection and for the utilization of multi-
modality therapy to limit morbidity. With this in mind, risk-adapted strategies designed to
preserve hypothalamic structures have been developed. The preliminary results of these
strategies appear to be encouraging. However, the long-term clinical outcome in terms of
post irradiation complications and management of relapses is currently unknown.
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TRADITIONAL SURGICAL APPROACH
Surgery for craniopharyngiomas has long been undertaken with a
degree of trepidation related in part to their intimate association
to the hypothalamus and their tendency to be calciﬁed. Resection
of these lesions therefore became a testament to surgical prowess
(Yasargil et al., 1990).
Historically, the fact that craniopharyngiomas are histologi-
callybenignmadethemanidealtargetforcurativeradicalsurgical
resection with one of the key goals being preservation of vision.
This was particularly so at the beginning of the microsurgical era
(Hoffman et al.,1977; Choux and Lena,1979;Yasargil et al.,1990;
Villani et al., 1997; Van Effenterre and Boch, 2002). Subsequent
recognition of appropriate surgical approaches and the additional
use of modern technologies including ultrasonic aspiration tools,
image-guided techniques, and neuroendoscopy further enhanced
the surgeon’s ability to attain radical resection such that cranio-
pharyngioma surgery reached a peak of enthusiasm during the
1990s. Leading ﬁgures such as Hoffman et al. (1992), Choux and
Lena(1979),Pierre-Kahnetal.(1988),Caldarellietal.(1998),and
Zuccaro (2005) published large pediatric surgical series showing
their surgical success in resecting craniopharyngiomas.
CRITICISM OF THE TRADITIONAL SURGICAL APPROACH
Following this enthusiasm for gross total resection, the associated
mortality (up to 50% at 10years) and the high rate of recur-
rencedespitesurgicalclearance(upto50%insomeseries)became
apparent (Shapiro et al., 1979; Carmel et al., 1982; McLone et al.,
1982;Sung,1982;Till,1982;Pierre-Kahnetal.,1988;Fischeretal.,
1990; Yasargil et al., 1990; Hoffman et al., 1992; Hetelekidis et al.,
1993; Tomita and McLone, 1993; De Vile et al., 1996b; Zuccaro
et al., 1996; Villani et al., 1997; Caldarelli et al., 1998; Zuccaro,
2005).
Endocrine disorders associated with radical resection of these
tumorswereconsideredbothinevitableand“acceptable.”Progress
in endocrinological medicine had enabled hormonal replacement
that was thought to be compatible with a “normal life” (Brauner
et al., 1987; Honegger et al., 1999). Endocrine dysfunction was
reported in up to 75% of affected children at presentation with
the most frequent being growth hormone deﬁciency (Thomsett
etal.,1980;Brauneretal.,1987;TomitaandMcLone,1993;Villani
etal.,1997;VanEffenterreandBoch,2002).Diabetesinsipiduswas
less frequent at diagnosis (6–35%) but its prevalence dramatically
increased post-operatively (50–100%) as did panhypopituitarism
(75%; Choux and Lena, 1979; Thomsett et al., 1980; Brauner
et al., 1987; Yasargil et al., 1990; Hoffman et al., 1992; Tomita
and McLone,1993;Weiner et al.,1994; Crotty et al.,1995; Blethen
et al.,1996; DeVile et al.,1996b; Zuccaro et al.,1996;Villani et al.,
1997;Van Effenterre and Boch, 2002; Puget et al., 2007).
Peri-operative injury to the hypothalamus, incompatible with
normal life due to hyperphagia, obesity, behavioral and memory
disorders,lossof neurovegetativehomeostasis,andanalteredneu-
ropsychological proﬁle were also recognized (Fisher et al., 1998;
Rivaetal.,1998;Mulleretal.,2005a;Pierre-Kahnetal.,2005;Puget
etal.,2007;Bawdenetal.,2009).Obesitywasreportedin4–58%of
children with craniopharyngiomas at diagnosis (Choux and Lena,
1979; Cabezudo et al., 1981; Carmel et al., 1982; Brauner et al.,
1987; Hoffman et al., 1992; Tomita and McLone, 1993; Weiner
et al., 1994; De Vile et al., 1996b; Zuccaro et al., 1996; Villani
et al., 1997; Riva et al., 1998; Puget et al., 2007) but its prevalence
increased dramatically, up to 81%, following surgery particularly
when radical surgery had been attempted (Brauner et al., 1987;
Yasargil et al., 1990; Hoffman et al., 1992; De Vile et al., 1996b;
Villani et al., 1997; Riva et al., 1998; Hayward, 1999; Puget et al.,
2007). De Vile et al. (1996a) showed that this obesity was related
to peri-operative hypothalamic injury.
Upto50%of childrenhadevidenceof memoryandbehavioral
disorders following craniopharyngioma surgery. Post-operative
performance scores of 1 (excellent) and 2 (good) were reported in
53–73and66–92%respectively,aftergrosstotalresectionandpar-
tial resection with radiotherapy. These complications, associated
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with aggressive surgical removal and the degree of hypothalamic
dysfunction,had an impact on quality of life (Clopper et al.,1977;
Hoffman et al., 1977; Cavazzuti et al., 1983; De Vile et al., 1996a;
Anderson et al., 1997; Villani et al., 1997; Donnet et al., 1999;
Habrand et al., 1999; Carpentieri et al., 2001; Merchant et al.,
2002; Poretti et al., 2004; Pierre-Kahn et al., 2005; Sands et al.,
2005; Dekkers et al., 2006; Karavitaki et al., 2006; Puget et al.,
2007; Muller,2011).
The recognition of hypothalamic involvement as the main
factorassociatedwithmorbidityledmanygroupstodeveloptreat-
ment strategies to avoid hypothalamic injury (Cavazzuti et al.,
1983; De Vile et al., 1996a; Fisher et al., 1998; Riva et al., 1998;
Carpentieri et al., 2001; Muller et al., 2001; Poretti et al., 2004;
Pierre-Kahn et al., 2005; Puget et al., 2007; Ondruch et al., 2011).
Peri-operativefactorsthatcouldpredicthypothalamicinjurywere
identiﬁed (De Vile et al., 1996a; Merchant et al., 2002; Albright
etal.,2005;Marchaletal.,2005;Mulleretal.,2005b,2006;Thomp-
sonetal.,2005;Spoudeasetal.,2006;GarreandCama,2007;Puget
et al., 2007). Several teams then utilized progress within radio-
therapy, such as conformal planning and proton beam therapy,
and built these into treatment strategies of multimodality ther-
apy (Hayward,1999;Merchant et al.,2002;Rutka,2002;Spoudeas
et al.,2006; Puget et al.,2007).
A NEW ERA OF SURGICAL MANAGEMENT WITH
PRESERVATION OF HYPOTHALAMIC STRUCTURES
Initial craniopharyngioma management is tailored to presenta-
tion.Raisedintracranialpressureorrapidvisuallossismanagedby
treating the associated hydrocephalus and/or tumor cyst decom-
pression.Purelycystictumorsmaybemanagedwiththeplacement
of a catheter to allow repeated aspiration. The use of intracystic
radiotherapy (Yttrium-90 and Phosphorus-32) or chemotherapy
with Bleomycin has not proven to be consistently efﬁcacious
(Voges et al., 1997; Albright et al., 2005; Marchal et al., 2005;
Takahashi et al., 2005; Steinbok and Hukin, 2010). With resolu-
tion of the intracranial hypertension, two-thirds of patients will
experience visual improvement (Garre and Cama, 2007).
Surgical resection of craniopharyngiomas is traditionally per-
formed via a transcranial route. The advent of the endoscope
enabled utilization of a trans-nasal route with the latter having
beenclaimedtoavoidhypothalamicdysfunction(Fahlbuschetal.,
1999; Zona and Spaziante, 2006). It should be noted however,
that the majority of tumors approached via this route were infra
diaphragmatic in location (Jane et al.,2010). The morbidity asso-
ciatedwithtranscranialresectionofcraniopharyngiomasislargely
dependentontumorlocationandmaybemodiﬁedbythesurgical
approachandtreatmentstrategy.Thompsonetal.(2005)reported
their results in terms of morbidity, mortality, and tumor recur-
rence when comparing two series of patients, one where the goal
wastotalresectionversusonewheretheaimwastoimprovequality
of lifeandreducemorbidity.Usingascoringgradeforvision,cog-
nition,motor function,hypothalamic dysfunction,and endocrine
disturbances,they concluded that they were able to improve qual-
ity of outcome without compromising tumor recurrence in their
latter series of patients.
In an attempt to analyze the role of aggressive surgical resec-
tion relative to the risk of signiﬁcant morbidity associated with
thisapproach,theauthorscritically reviewedaretrospectiveseries
where there had been an intention of gross total resection in
all cases (Puget et al., 2007). Classiﬁcation of tumors at pre-
sentation was performed in order to rationalize multimodality
therapy.Speciﬁcally,thepre-andpost-operativeMRIweregraded
with respect to the degree of hypothalamic involvement/injury
(Figures 1 and 2). As previously shown (De Vile et al., 1996a),
it was conﬁrmed that quality of life outcomes (using the Health
UtilityIndex2,HUI2)werecorrelatedwiththedegreeofhypothal-
amicinjuryasevidentonthepost-operativeMRI(p =0.003).The
post-operative BMI and quality of life were linked to hypothala-
mic involvement as assessed on the pre-operative MRI (p =0.007
and p =0.001 for BMI Z score and HUI2 score respectively). This
ﬁnding has subsequently been conﬁrmed in a large, multicentre
prospectivestudywheretheonlyindependentriskfactorforsevere
obesity, on multivariate analysis, was the degree of pre-operative
hypothalamic involvement (p =0.002; Muller et al., 2011) Using
the MRI grading scheme described above (Puget et al.,2007).Van
Gompeletal.(2010)inalargecohortof296adultpatients,showed
a good correlation between the degree of pre-operative hypothal-
amic involvement and post-operative weight gain (p =0.022).
The likelihood of hypothalamic damage may be predicted
by the degree of pre-operative hypothalamic involvement and
FIGURE1|P r e-operative MRI classiﬁcation according to hypothalamic involvement.Type 0 pre-op: no involvement of the hypothalamus,Type 1 pre-op:
distortion/elevation of the hypothalamus,Type 2 pre-op: the hypothalamus is not visible due to tumor invasion.
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FIGURE2|P ost-operative MRI classiﬁcation according to hypothalamic injury.Type 0 post-op: intact hypothalamus,Type 1 post-op: breech/residue on the
hypothalamus,Type 2 post-op: severe hypothalamic injury.
FIGURE 3 | Surgical strategy grade 0/1 pre-op. (A) On the pre-operative
MRI, the hypothalamus appeared to be more displaced than invaded by
tumor (Type 1 pre-op). (B)This was conﬁrmed during surgery and a
complete removal preserving the hypothalamus could be achieved (Type 0
post-op).
surgical skill (Sanford, 1994; Boop, 2007; Puget et al., 2007).
Treatment strategies should therefore be adapted to the degree
of pre-operative hypothalamic involvement, MRI type 0, 1, and
2, in order to minimize morbidity. For those where the cranio-
pharyngioma does not involve the hypothalamus (type 0 pre-op),
total resection is suitable (Figure 3); when the tumor compresses
the hypothalamus (type 1 pre-op), total resection may still be the
best solution. However,the outcome will depend on the surgeon’s
skill in this domain. Finally, when the tumor involves the hypo-
thalamus (type 2 pre-op), subtotal resection with respect to the
involved hypothalamus combined with local irradiation currently
appears to be the better option (Figure 4).
This surgical strategy was analyzed in a prospective series of 70
childhood craniopharyngiomas treated in our institution since
2002. Based on the above algorithm, half of the patients had
a total removal; the others received radiotherapy after incom-
plete removal. We observed a signiﬁcant statistical decrease in
morbid obesity and in BMI Z scores in our prospective series
when compared to the historical cohort (publication in press).
Children treated with an intention to avoid hypothalamic
injury had less endocrine dysfunction than those previously
reportedinpuresurgicalseries.Questionsarestartingtoberaised
about the “normality” achieved despite hormone replacement as
FIGURE 4 | Surgical strategy grade 2 pre-op. (A) At referral, the patient
had severe intracranial hypertension secondary to obstructive
hydrocephalus from a large intraventricular cyst of the third ventricle. An
Ommaya reservoir was placed within the cyst as a matter of urgency.The
tumor clearly invaded the hypothalamus (Type 2 pre-op) therefore the goal
of surgery was to perform a subtotal removal leaving that component. (B)
The residual lesion, attached to the infundibulum, which could not safely be
removed.
more subtle issues such as fertility, adult growth hormone deﬁ-
ciency,anditsassociationwithlowbonemineraldensityarebeing
critically reviewed (Islas Cruz et al., 2004; Poretti et al., 2004;
Holmer et al., 2011).
THE ROLE OF RADIOTHERAPY
In a recent extensive review of the literature, Kiehna showed that
radiotherapy may provide long-term tumor control for pediatric
craniopharyngiomas, with the more recent studies reporting at
least80%diseasecontrolat10-years(Habrandetal.,2006;Kiehna
and Merchant, 2010) and a favorable functional outcome in 42–
86% of cases (Kiehna and Merchant,2010). The main criticism of
incorporating radiotherapy into a treatment strategy has been the
well documented associated risks of late-onset vascular damage
(particularly Moya–Moya syndrome; Sanford, 1994), secondary
tumor genesis (Kranzinger et al., 2001; Caldarelli et al., 2005;
Aquilina et al., 2010), and late cognitive effects (Merchant, 2006).
Merchant et al. (2002) found a signiﬁcant difference in full-scale
IQ following gross total resection compared to limited resection
followed by irradiation (9.8 points versus 1.25 respectively). They
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also showed that IQ remained stable over 5years of follow-up
(Merchant, 2006).
Conformal radiation therapy is currently considered the most
appropriateradiationtechniqueforthisdiseaseinducinglessneu-
rocognitive dysfunction when compared to conventional external
beam radiotherapy (Kiehna et al., 2006; Scarzello et al., 2006;
Minniti et al., 2007; Kiehna and Merchant, 2010) with favor-
able outcomes occurring in at least 85% of children (Merchant
et al., 2002). There is a growing interest in proton beam irradi-
ation in this disease with its potential to reduce the incidence of
neurocognitive disorders and the late effects of irradiation to the
optic pathway and hypothalamus. Preliminary results are promis-
ing (Baumert et al., 2004; Fitzek et al., 2006; Luu et al., 2006).
For Merchant and his team, proton therapy has the potential to
signiﬁcantly reduce whole-brain and -body irradiation (Beltran
et al., 2012) and, using dose-cognitive effects models, have shown
that a reduction in the lower-dose volumes or mean dose would
havelong-term,clinicaladvantageforchildrenwithcraniopharyn-
giomas (Merchant et al., 2008). They also compared photon- and
proton-basedirradiationmethodstodeterminetheeffectoftumor
volumechangeontargetcoverageandnormaltissueirradiationin
craniopharyngiomas. They have shown that proton therapy efﬁ-
cacyandsafetyishighlysensitivetotargetvolumechanges.Inlight
of this and the ﬁndings of Merchant we believe that it is impor-
tant that irradiation is targeted to a mostly solid lesion with cystic
components aspirated or resected prior to irradiation.
The risk of progression following incomplete resection alone
is 71–90% whereas it is estimated to be in the order of 15–20%
whenfollowedbyradiotherapy(Fischeretal.,1990;Habrandetal.,
1999;KiehnaandMerchant,2010).Mulleretal.(2011)hasshown
in a prospective multicentre analysis that the risk of progression
was 88% lower in irradiated patients than in patients without
radiotherapy. However long-term follow-up,beyond the 5- to 10-
years necessary to assess tumor recurrence relative to functional
outcome, is lacking.
The most appropriate timing for radiotherapy following
incompleteresectionisstillunknown.Moonetal.(2005)advocate
early radiotherapy to improve quality of life rather than at tumor
progressionwithfurthersurgeryandapotentiallyworseoutcome.
Theoptimaltimingtopreventtumorrecurrencefollowingincom-
plete resection is currently being investigated in an international
trial(Mulleretal.,2011).Thisissueisof criticalinterestasthenat-
ural history of craniopharyngioma residua remains unpredictable
withcurrentlynoclinical,radiological,orhistologicalfeaturesable
to differentiate those which will behave aggressively from those
which will stay quiescent for many years.
THE ROLE OF BIOLOGY
The identiﬁcation of speciﬁc biological markers of aggressiveness
may therefore help to stratify patients and guide the development
of risk-adapted strategies and novel treatments. To date, only a
few studies have given insight into craniopharyngioma biology.
Katoetal.(2004)showednuclear/cytoplasmicaccumulationof β-
catenin in typical adamantinomatous type craniopharyngiomas.
Moreover, β-catenin mutations have been found in a subset of
adamantinomatous type craniopharyngiomas but not in other
pituitarytumors(Sekineetal.,2002;Katoetal.,2004;Oikonomou
et al.,2005). These ﬁndings suggest that the pathogenesis of pedi-
atriccraniopharyngiomasisassociatedwithabnormalitiesof Wnt
signaling, but thus far is unable to predict craniopharyngioma
progression. Interestingly, in a mixed series of adults and pedi-
atric craniopharyngiomas, Lefranc et al. (2003) found low levels
of retinoic acid receptor β (RARβ), galectin-3, and Macrophage
migration Inhibitory Factor (MIF) and high levels of retinoic acid
receptor γ (RARγ) to be associated with a higher risk of relapse.
The role of these proteins in craniopharyngioma pathogenesis is
still unclear. The role of estrogen and progesterone receptors (ER
and PR respectively) has been described in another mixed series
(Izumoto et al., 2005) showing that positive immunostaining for
these markers was inversely linked with the risk of relapse. The
main criticism of these papers is the lack of multivariate analyses
and the lack of analysis of the quality of resection.
CONCLUSION
The morbidity and mortality after total resection of pediatric
craniopharyngioma is well documented. There is an increasing
advocacy among experts for limited resection followed by radio-
therapy in speciﬁc cases. With a more conservative approach
becoming universally adopted it is important not to ignore those
whopresentasanabsolutesurgicalemergencywithhydrocephalus
or chiasmatic compression. Total resection must remain the goal
for those craniopharyngiomas that do not involve hypothalamic
structures. For the rest, we now have a wealth of knowledge
and modern techniques in imaging, surgery, and radiotherapy
at our disposal to customize treatment thereby avoiding hypo-
thalamic injury with its consequent devastating effects. In the
swinging pendulum from aggressive to conservative treatment
(Sainte-Rose et al., 2005), we need to be cognizant not only of
oursurgicallimitationsbutalsothelimitationsof othertreatment
modalities.
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